Literature DB >> 22009571

Cloning and expression of a highly active recombinant alkaline phosphatase from psychrotrophic Cobetia marina.

Eriko Nasu1, Atsushi Ichiyanagi, Keiko Gomi.   

Abstract

Alkaline phosphatase catalyzes the hydrolysis of phosphomonoesters and is widely used in molecular biology techniques and clinical diagnostics. We expressed a recombinant alkaline phosphatase of the marine bacterium, Cobetia marina, in Escherichia coli BL21 (DE3). The recombinant protein was purified with a specific activity of 12,700 U/mg protein, which is the highest activity reported of any bacterial alkaline phosphatase studied to date. The molecular mass of the recombinant protein was 55-60 kDa, as determined by SDS-PAGE, and was observed to be a dimer by gel filtration analysis. The enzyme was optimally active at 45°C and the recombinant alkaline phosphatase efficiently hydrolyzed a phosphoric acid ester in luminescent and fluorescent substrates. Therefore, this enzyme can be considered to be extremely useful as a label conjugated to an antibody.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009571     DOI: 10.1007/s10529-011-0772-8

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  3 in total

1.  Recombinant production and characterization of a highly active alkaline phosphatase from marine bacterium Cobetia marina.

Authors:  Vasily Golotin; Larissa Balabanova; Galina Likhatskaya; Valery Rasskazov
Journal:  Mar Biotechnol (NY)       Date:  2014-09-27       Impact factor: 3.619

2.  Complete genome sequencing and comparison of two nitrogen-metabolizing bacteria isolated from Antarctic deep-sea sediment.

Authors:  Wenqi Liu; Bailin Cong; Jing Lin; Linlin Zhao; Shenghao Liu
Journal:  BMC Genomics       Date:  2022-10-19       Impact factor: 4.547

3.  A Novel Alkaline Phosphatase/Phosphodiesterase, CamPhoD, from Marine Bacterium Cobetia amphilecti KMM 296.

Authors:  Yulia Noskova; Galina Likhatskaya; Natalia Terentieva; Oksana Son; Liudmila Tekutyeva; Larissa Balabanova
Journal:  Mar Drugs       Date:  2019-11-22       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.